Difference of Clinical Parameters and Correlation between Type-1 and Type-2 Diabetes Mellitus (DM) Subjects in Bangladesh


  • Khaleda Ferdous Bangladesh University of Health Sciences (BUHS), Bangladesh
  • Md. Ashiqur Rahman Novus Clinical Research Services Limited (NCRSL), Bangladesh https://orcid.org/0000-0002-9430-5547
  • Sadia Islam Bangladesh Specialized Hospital Limited (BSHL), Bangladesh
  • Sadia Tasnim Bangladesh University of Health Sciences (BUHS), Bangladesh
  • Shohanur Rahaman Diabetic Association of Bangladesh (BADAS) COVID-19 Diagnostic Laboratory, Bangladesh
  • Md. Raihanul Islam Novus Clinical Research Services Limited (NCRSL), Bangladesh
  • Md. Biplob Hossain Diabetic Association of Bangladesh (BADAS) COVID-19 Diagnostic Laboratory, Bangladesh
  • Saraf Tasnim Bangladesh University of Health Sciences (BUHS), Bangladesh




Type-1 DM, Type-2 DM, FPG, HbA1C, Lipid Profile


Type I and Type 2 diabetes are the two main types with types diabetes accounting for the majority (>85%) of total diabetes prevalence. Both forms of diabetes can lead to multisystem complications of microvascular endpoints including retinopathy, nephropathy and neuropathy and microvascular endpoints including is cadmic heart disease, stroke and peripheral vascular disease. The premature morbidity, mortality, reduced life expectancy and financial and other others costs of diabetes make if an important public health condition. The aim of this study was to observe the clinical condition and consequences patients with diabetes mellitus in Bangladesh. A descriptive cross-sectional study was conducted for the study. Data are collected from BIHS General Hospital. The results showed that, among 100 patients 20% patient was affected by Type-1 Diabetes Mellitus (DM) and 80% patient was affected by Type-2 Diabetes Mellitus (DM). In comparison between Type-1 and Type-2 DM patient’s result showing that Fasting Plasma Glucose (FPG) and 2 hour ABF plasma Glucose range is slightly high in Type-1 DM than Type-2 DM. On the other hand, Creatinine, HbA1C, TSH, Total cholesterol (TC), Triglycerides (TG), HDL ranges are increased in Type-2 DM patient. In this study males are affected 62% and females are 32%. So the ratio between male and female is 2:3. More patients were found in the age between 50-60 years and has risk among 40-50 years. Eating the right foods and adopting other life style behaviors that promotes healthy blood sugar and insulin levels will give you the best chance at avoiding diabetes.


Download data is not yet available.


Afroz, A., Alam, K., Ali, L., Karim, A., Alramadan, M. J., Habib, S. H., ... & Billah, B. (2019). Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of- illness study. BMC health services research, 19(1), 1-12

Alberti, K. G. M. M., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic medicine, 15(7), 539-553

Chaikledkaew, U., Pongchareonsuk, P., Chaiyakunapruk, N., & Ongphiphadhanakul, B. (2008). Factors affecting health‐care costs and hospitalizations among diabetic patients in Thai public hospitals. Value in health, 11, S69-S74

Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., ... & Buse, J. B. (2018). Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care, 41(12), 2669-2701

Islam, S., Hossen, M. A. A., Rahman, M. A., Lubaba, M. I., & Akram, A. (2022). Serum uric acid level among type-2 diabetes subjects attending in a tertiary hospital of Bangladesh. World Journal of Biology Pharmacy and Health Sciences, 12(1), 081-085.

Khowaja, L. A., Khuwaja, A. K., & Cosgrove, P. (2007). Cost of diabetes care in out-patient clinics of Karachi, Pakistan. BMC health services research, 7(1), 1-8

Krop, J. S., Powe, N. R., Weller, W. E., Shaffer, T. J., Saudek, C. D., & Anderson, G. F. (1998). Patterns of expenditures and use of services among older adults with diabetes: implications for the transition to capitated managed care. Diabetes care, 21(5), 747-752

Kuzuya T, Matsuda A. (1997). Classification of diabetes on the basis of etiologies versus degree of insulin deficiency. Diabetes care, 20(2), 219-220

Magliano, D. J., Zimmet, P., & Shaw, J. E. (2015). Classification of diabetes mellitus and other categories of glucose intolerance. International textbook of diabetes mellitus, 1-16

Mitrofanova, A., Sosa, M. A., & Fornoni, A. (2019). Lipid mediators of insulin signaling in diabetic kidney disease. American Journal of Physiology-Renal Physiology, 317(5), F1241-F1252

Murphy, R., Ellard, S., & Hattersley, A. T. (2008). Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nature clinical practice Endocrinology & metabolism, 4(4), 200-213

Rosediani, M., Azidah, A. K., & Mafauzy, M. (2006). Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine. The Medical Journal of Malaysia, 61(1), 67-71

Roy, P. (2016). Clinical Significance of HbA1c in the Management of Complicated Type 2 Diabetic Patients in Bangladesh. Malaysian Journal of Medical and Biological Research, 3(2), 69-74

Sato, K. K., Hayashi, T., Harita, N., Yoneda, T., Nakamura, Y., Endo, G., & Kambe, H. (2009). Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: The Kansai Healthcare Study. Diabetes Care, 32(4), 644-646

Spyer, G., Macleod, K. M., Shepherd, M., Ellard, S., & Hattersley, A. T. (2009). Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabetic Medicine, 26(1), 14-18

Stride, A., Vaxillaire, M., Tuomi, T., Barbetti, F., Njølstad, P. R., Hansen, T., ... & Hattersley, A. T. (2002). The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia, 45, 427- 435.

Tharkar, S., Devarajan, A., Kumpatla, S., & Viswanathan, V. (2010). The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diabetes research and clinical practice, 89(3), 334-340

Tuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., & Mackay, I. R. (1993). Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non—insulin-dependent onset of disease. Diabetes, 42(2), 359-362

Vanderlee, L., Ahmed, S., Ferdous, F., Farzana, F. D., Das, S. K., Ahmed, T., ... & Faruque, A. S. G. (2016). Self-care practices and barriers to compliance among patients with diabetes in a community in rural Bangladesh. International Journal of Diabetes in Developing Countries, 36, 320-326

Vionnet, N., Stoffel, M., Takeda, J., Yasuda, K., Bell, G. I., Zouali, H., ... & Cohen, D. (1992). Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature, 356(6371), 721-722

Wang, W., McGreevey, W. P., Fu, C., Zhan, S., Luan, R., Chen, W., & Xu, B. (2009). Type 2 diabetes mellitus in China: a preventable economic burden. The American journal of managed care, 15(9), 593-601

Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., ... & Coward, R. J. (2010). Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell metabolism, 12(4), 329-340

World Health Organization. (1985). Diabetes Mellitus: Report of a WHO Study Group [meeting held in Geneva from 11 to 16 February 1985].

World Health Organization, (1999). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO, 1999. Report No. WHO/NCD/NCS/99.2.




How to Cite

Ferdous, K., Rahman, M. A., Islam, S., Tasnim, S., Rahaman, S., Islam, M. R., Hossain, M. B., & Tasnim, S. (2023). Difference of Clinical Parameters and Correlation between Type-1 and Type-2 Diabetes Mellitus (DM) Subjects in Bangladesh. American Journal of Life Science and Innovation, 2(3), 1–7. https://doi.org/10.54536/ajlsi.v2i3.1928